Oral salmon acylated ghrelin increases food intake in common carp (Cyprinus carpio) via ghrelin receptors, likely through sensory nerves rather than systemic absorption.
This animal study investigated whether orally administered salmon acylated ghrelin (sAG) could stimulate food intake in common carp (Cyprinus carpio) and sought to identify the local mechanism behind any such effect. Carp were fed experimental diets containing a range of sAG concentrations in single-shot feeding trials, and additional voluntary feed intake was measured afterward. The study found that diets containing sAG at or above a certain threshold produced a significant, dose-dependent increase in feed intake that plateaued at higher concentrations. Notably, plasma ghrelin levels did not rise following oral administration, as confirmed by two separate radioimmunoassay methods, suggesting that sAG was not absorbed into the bloodstream. To probe the mechanism, researchers used a ghrelin receptor antagonist ([D-Lys3]-GHRP-6) and capsaicin — both abolished the orexigenic effect — pointing to a local signaling pathway involving growth hormone secretagogue receptors and peripheral sensory (likely vagal afferent) neurons. The authors propose this represents a non-circulatory gut-brain axis mechanism in fish. Limitations include that results are limited to a single fish species under controlled laboratory conditions, and translation to other vertebrates or aquaculture settings requires further research.
Why this grade: All experiments were conducted exclusively in common carp (Cyprinus carpio) under controlled laboratory conditions, with no human or clinical data presented.
This study clarified the local mechanism of action and assessed the aquaculture potential of orally administered salmon acylated ghrelin (sAG) on feed intake in common carp (Cyprinus carpio). Experimental diets containing sAG (ranging from 0.001 to 13.04 µg/g) were prepared and fed to carp at 2.0 % of body weight (BW) in single-shot trials. Fish receiving diets of 0.64 µg/g (1.3 µg/100 g BW) or higher exhibited a significant, dose-dependent increase in additional feed intake, plateauing at 1.20 µg/g (2.4 µg/100 g BW). Despite this behavioral effect, plasma ghrelin levels remained unchanged, as measured by both N-terminal and salmon-specific C-terminal radioimmunoassays, confirming that sAG was not systemically absorbed. The orexigenic effect was abolished by pretreatment with the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or with capsaicin, demonstrating local sAG action via growth hormone secretagogue receptor signaling and peripheral sensory neurons (likely vagal afferents). These findings provide the first evidence that fish ghrelin exerts biological activity via a non-circulatory neuroendocrine pathway. This advances our understanding of the vertebrate gut-brain axis and highlights the potential of harnessing locally acting peptides for physiological modulation in aquatic species.
Educational summary of published research — not medical advice. Full text is shown only where licensing permits.